That CHMP5 deficiency -which mitigated T-ALL disease initiation and maintenance- impaired p300 recruitment to BRD4 is consistent with a pro-tumorigenic role for p300 in T-ALL pathogenesis. The gene discussed is EP300; the disease is acute lymphoblastic leukemia.